Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

BACKGROUND: New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Andersen, John D, Boylan, Kristin LM, Jemmerson, Ronald, Geller, Melissa A, Misemer, Benjamin, Harrington, Katherine M, Weivoda, Starchild, Witthuhn, Bruce A, Argenta, Peter, Vogel, Rachel Isaksson, Skubitz, Amy PN
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949730/
https://ncbi.nlm.nih.gov/pubmed/20831812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-3-21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados